Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a randomized double-blind parallel-group study of PF-06651600 in rheumatoid arthritis
2016-002862-30Phase 2Completed
- Sponsor
- Pfizer
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing PF-06651600 with Placebo (2 arms). Primary endpoint: Change from baseline in simple disease activity index. Started Nov 2016; status: completed.
02
Drugs
ritlecitinib tosilate
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2016-002862-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002862-30.